Lipocalyx and Georgia Tech Team Up for Influenza Program

Atlanta / Halle, Sep 30th, 2019. Lipocalyx, a leading developer of delivery systems for RNA therapeutics today announced collaboration with researchers from Georgia Tech to develop novel treatments for influenza. Under the agreement, the Atlanta, Georgia, based group led by Phil Santangelo will identify and develop novel treatments for pandemic flu using mRNA. The German Lipocalyx [...]

By | 2019-10-16T17:36:59+00:00 October 16th, 2019|Allgemein|Comments Off on Lipocalyx and Georgia Tech Team Up for Influenza Program